Below is an important message from one of our highly valued sponsors. Please read it carefully as they have some special information to share with you.
Dear reader,
I recently sat down with the famous economist and best-selling author…
Who predicted the biggest stock market crashes of the last two decades…
And he’s now predicting this AI giant is about to go bust…
Trigging a full-blown AI meltdown that could wipe out 80% of the stock market.
The first time I heard about it…
I thought he was talking about Nvidia.
But it’s another company he says is far more important.
Look, the stakes here couldn’t be any higher…
Because this is the same man who predicted the 2008 meltdown…
Just three weeks before Lehman Brothers imploded and the stock market collapsed.
And the same man who predicted the Covid meltdown…
Again just three weeks before the stock market suffered the fastest drop in history.
And now he’s predicting that this coming AI meltdown will be 10 times bigger than Lehman Brothers...
….and it could send a ripple effect through the market that could crater the entire AI industry.
And he’s warning everyone to take five simple steps to prepare.
Click here to see the details.
Regards,
Aaron Gentzler
VP of Research, Paradigm Press
Frozen Out: Lamb Weston Beats Earnings, but the Stock Still Slides
Written by Chris Markoch. First Published: 4/2/2026.
Key Points
- Lamb Weston stock appears undervalued after its post-earnings decline, with much of the negative sentiment around margin pressure already priced in.
- The company’s Focus to Win initiative, cost-cutting efforts, and declining input costs could help drive margin recovery and improved profitability in fiscal 2027.
- With steady demand, a nearly 4% dividend yield, and over 30% implied upside based on analyst targets, LW stock presents an asymmetric opportunity for long-term value investors.
- Special Report: Have $500? Invest in Elon's AI Masterplan
Lamb Weston (NYSE: LW), a market leader in frozen potatoes for both retail and foodservice, beat expectations on both revenue and adjusted EPS in its Q3 FY2026 earnings report on April 1.
Despite the beats, investors have largely frozen out LW stock, which is down over 8% in 2026 so far. The chart suggests much of the negative news is already priced in—potentially creating an asymmetric opportunity for patient buyers.
More valuable than gold at a 94% discount (Ad)
Gold prices are surging, but there may be a more compelling way to play the rally. A little-known asset called 'Canadian Gold' has outpaced physical gold, silver, the NASDAQ, and the S-P 500 since its inception.
Research shows that 'the Warren Buffett of Canada' and a close associate of Warren Buffett himself are both quietly accumulating positions in this overlooked alternative.
Click here to discover why Canadian Gold is drawing serious investor attentionThe company reported quarterly revenue of $1.56 billion, above estimates of $1.49 billion and higher than the $1.52 billion posted in Q3 FY2025.
Adjusted earnings per share also topped estimates: analysts expected $0.63, while Lamb Weston delivered $0.72. Still, that result was well below last year's $1.10 adjusted EPS in Q3 FY2025, underscoring a trend investors have been watching for several quarters.
Right Strategy, Wrong Timing
The core issue is straightforward: Lamb Weston continues to grow sales in a challenging macro environment, but earnings have fallen. Management pointed to margin pressure from industry supply dynamics, factory utilization and softer demand in some markets.
Some of those factors are outside the company's control, but the problem emerged in 2023 after an aggressive international expansion—growth that has its own execution risks. A slowdown in restaurant traffic across key overseas markets has amplified the drag on profitability.
In response—partly under pressure from an activist investor—management launched the Focus to Win initiative at the start of fiscal 2026 and set a $250 million cost-savings target, which it says is on track to exceed.
What the Results Don't Show
The market reaction appears tied to guidance for continued operating-margin pressure, which is a legitimate concern and one the company may not fully control. Low single-digit revenue growth alongside negative earnings growth isn't ideal, but top-line momentum—particularly in North America—still matters.
That momentum runs counter to the narrative that consumers are abandoning processed potato products at home or when dining out. It's also notable that Lamb Weston supplies McDonald's (NYSE: MCD), a customer that continues to hold up relatively well.
Lower Input Costs May Help Build Cash
An underappreciated tailwind is the outlook at the farm level. Management expects North American contracted potato prices for 2026 to decline by a low-to-mid single-digit percentage, while European contracted raw potato costs could fall by the mid-teens versus 2025.
If lower input costs begin to flow through in fiscal 2027, that could be a meaningful catalyst for margin recovery—especially if North American volume momentum persists. Add $339 million in year-to-date free cash flow and a $100 million reduction in the capital-expenditure plan, and the company's financial-discipline story looks more credible than the current stock price suggests.
LW Stock Now Looks Like a Deep Value
The LW chart isn't pretty, but it paints a possible opportunity for long-term, value-oriented investors. The stock sold off sharply after the December 2025 earnings report in what looked like a panic-driven move that likely shook out many sellers. Since then, volatility has moderated.
With shares trading at levels not seen since 2017, a value thesis could be forming. Analysts on MarketBeat show a consensus price target of $51.50, implying about 31.5% upside. The company also has a nine-year streak of dividend increases and a current yield of 3.9%.
By conventional measures (price-to-earnings, price-to-sales, price-to-book), Lamb Weston trades below its historical averages and at a discount to the broader consumer staples sector. That setup can offer asymmetric risk/reward for patient investors.
The negative developments appear largely priced in; the key question is how long the international drag will persist. There's no easy answer in the chart, but with a dividend that pays investors to wait, Lamb Weston could offer upside later in the year for those willing to tolerate near-term margin risk.
Phreesia Hits Bottom in Q1: Rebound Ahead, Timing Uncertain
By Thomas Hughes. Date Posted: 4/2/2026.
Key Points
- Phreesia is well-positioned as a growing health-oriented fintech, providing patient intake and payment services.
- Reduced guidance sparked market capitulation, with retail investors bowing out, leaving the stock at rock-bottom prices as Q1 2026 ended.
- Analysts' revisions aided the downdraft; institutional trends suggest they bought the stock, providing a floor for Q2.
- Special Report: Have $500? Invest in Elon's AI Masterplan
For years, Phreesia, Inc. (NYSE: PHR) has seen its stock price struggle. Those challenges are not the company's fault but are largely a consequence of growth financed by share issuance and debt. As Phreesia has added technology and expanded its offerings, its share count has risen noticeably since 2024. And despite the stock losing nearly 50% in Q1 2026, the Q2 narrative is that the market capitulated after Phreesia's 2026 guidance update — creating a deep-value opportunity in a quality healthcare-technology speculation.
Phreesia provides automated patient intake services for healthcare providers, is growing at a robust pace, and has moved toward sustained profitability. That improving profitability underpins the stock's outlook and presents clear value for long-term investors.
Phreesia Growth Outlook Underestimates Potential
More valuable than gold at a 94% discount (Ad)
Gold prices are surging, but there may be a more compelling way to play the rally. A little-known asset called 'Canadian Gold' has outpaced physical gold, silver, the NASDAQ, and the S-P 500 since its inception.
Research shows that 'the Warren Buffett of Canada' and a close associate of Warren Buffett himself are both quietly accumulating positions in this overlooked alternative.
Click here to discover why Canadian Gold is drawing serious investor attentionIndustry trends suggest Phreesia's revenue growth outlook may be too conservative. Healthcare is undergoing a systemwide overhaul — including digitization, artificial intelligence adoption, and workflow automation — all tailwinds for Phreesia's products and services.
Analysts expect the total addressable market to double over the next eight years, which would far outpace Phreesia's current projections. With the company's projected compound annual growth rate in the low single-digits, there is room for the business to exceed expectations as market adoption accelerates.
Catalysts in 2026 include the integration of AccessOne, a health-focused fintech that provides flexible patient payment solutions. AccessOne should expand Phreesia's client base, improve payment options and outcomes, and is expected to account for more than 25% of the company's payment processing volume by 2028. Management noted on the most recent earnings call that it will increase spending to accelerate the acquisition's rollout — and AccessOne may not be the last strategic acquisition.
The impact on the company's balance sheet is clear. Debt increased while cash declined, but this was offset by rises in assets, revenue and cash flow, and shareholders' equity also grew. The company is well-capitalized today, though future acquisitions could require additional financing and present a risk to leverage if not managed carefully.
Phreesia Had a Strong Quarter, but Visibility Limits Upside in Early 2026
Phreesia reported a solid quarter to close fiscal 2026. Net revenue was $127.07 million, up nearly 16% year-over-year and ahead of expectations. Revenue growth was driven by a 7% increase in clients and an 8% increase in revenue per client, both positive signs for upcoming quarters.
Margins disappointed, though perhaps less severely than the roughly 30% post-release selloff suggests. The company remained profitable for a third consecutive quarter but missed EPS expectations — reporting $0.02 versus an estimate of about $0.06. Other metrics were stronger: free cash flow (FCF) came in at $28.5 million, up more than 200%, and management expects FCF to remain robust.
The larger driver of the selloff was guidance and analysts' reaction. Phreesia trimmed its revenue outlook due to reduced visibility, prompting analysts to lower price targets. As the company progresses through the fiscal first half, visibility should improve, which could firm up guidance and sentiment.
MarketBeat recorded multiple price-target reductions, with the low end settling around $10 — roughly 25% above the post-release lows — suggesting limited downside from recent levels if visibility recovers.
Phreesia Hits Bottom: Institutional Buyers Drive Volume
Post-release price action was volatile, but it fits the thesis that the stock may have bottomed. Volume spiked to record levels, indicating institutional interest. Institutional data show they own more than 92% of the stock, have been net buyers for six consecutive quarters, and increased activity in Q1 2026.
That institutional accumulation provides a meaningful support base. At the same time, a current short interest of about 7% is a moderating factor — not extreme, but high enough to add downside pressure in the near term. Still, the roughly 30% decline following a longer downtrend creates an attractive entry opportunity for investors who view the company's fundamentals and market position favorably.
This message is a paid advertisement provided by Paradigm Press, a third-party advertiser of MarketBeat. Why was I sent this message?.
If you have questions or concerns about your subscription, feel free to contact MarketBeat's U.S. based support team at contact@marketbeat.com.
If you would no longer like to receive promotional emails from MarketBeat advertisers, you can unsubscribe or manage your mailing preferences here.
© 2006-2026 MarketBeat Media, LLC.
345 North Reid Place #620, Sioux Falls, S.D. 57103. United States of America..